<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate the dependence on the serum cofactor of anticardiolipin antibodies (aCL) in infectious and <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We also studied their correlation with some clinical manifestations, specially <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: aCL were determined with a standard ELISA method, and a modified ELISA in which we substituted bovine serum albumin (BSA), gelatin and skim milk powder for fetal calf serum (FCS) </plain></SENT>
<SENT sid="3" pm="."><plain>Categorized variables were analyzed by means of the chi 2 test and Fisher's test </plain></SENT>
<SENT sid="4" pm="."><plain>Four groups of patients were studied </plain></SENT>
<SENT sid="5" pm="."><plain>Group 1 </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with aCL and <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> (<z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> [SLE] and the <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> [PAPS]) </plain></SENT>
<SENT sid="7" pm="."><plain>Group 2 </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with aCL, no symptoms and no underlying <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> or <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Group 3 </plain></SENT>
<SENT sid="10" pm="."><plain>Patients with aCL and <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e> (<z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e>, <z:e sem="disease" ids="C0023343" disease_type="Disease or Syndrome" abbrv="">leprosy</z:e>, <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> and Q <z:hpo ids='HP_0001945'>fever</z:hpo>) </plain></SENT>
<SENT sid="11" pm="."><plain>Group 4 </plain></SENT>
<SENT sid="12" pm="."><plain>Control group </plain></SENT>
<SENT sid="13" pm="."><plain>RESULTS: (a) 19 of 20 samples from patients in Group 1 disclosed cofactor dependence in aCL activity </plain></SENT>
<SENT sid="14" pm="."><plain>(b) 17 of 19 samples from patients in Group 3 had aCL activity, that was independent of the presence of the cofactor </plain></SENT>
<SENT sid="15" pm="."><plain>(c) 3 of 4 patients in Group 2 had cofactor independent aCL and one had cofactor dependent aCL activity </plain></SENT>
<SENT sid="16" pm="."><plain>(d) no control group patient had aCL </plain></SENT>
<SENT sid="17" pm="."><plain>(e) association of cofactor dependent aCL with the development of clinical manifestations (<z:mp ids='MP_0005048'>thrombosis</z:mp>) was statistically significant (p &lt; 0.0001) </plain></SENT>
<SENT sid="18" pm="."><plain>(g) cofactor dependent aCL and cofactor independent aCL were, respectively, associated with autoimmune and <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e> (p &lt; 0.0001) </plain></SENT>
<SENT sid="19" pm="."><plain>CONCLUSIONS: (a) Dependence or independence of the cofactor helps to differentiate "infectious" aCL from "autoimmune" aCL </plain></SENT>
<SENT sid="20" pm="."><plain>(2) aCL related clinical manifestations (<z:mp ids='MP_0005048'>thrombosis</z:mp>) depends on the presence of cofactor dependent aCL and not on cofactor independent aCL </plain></SENT>
</text></document>